Medical Devices APAC

APAC Anastomosis Devices Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

APAC Anastomosis Devices Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Type, By Application, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $714.9 Mn Placeholder estimate
Estimate 2025 $772.6 Mn 21.5% of the global market
Projected 2034 $1.55 Bn 101.1% Adds $780.8 Mn over 9 forecast years
CAGR 2025–2034 8.07% Faster than 26% of 173 Medical Devices markets here
Key players 7 +2
  • APAC is 21.5% of the global market.
  • Among regions, the largest is North America at $1.76 Bn.
  • Fastest growing: Africa at 8.3% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$780.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Anastomosis Devices Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $714.9 Mn — —
2025 (base) $772.6 Mn +$57.7 Mn —
2026 (forecast) $834.9 Mn +$62.3 Mn +8.1%
2027 (forecast) $902.3 Mn +$67.4 Mn +16.8%
2028 (forecast) $975.1 Mn +$72.8 Mn +26.2%
2029 (forecast) $1.05 Bn +$78.7 Mn +36.4%
2030 (forecast) $1.14 Bn +$85.0 Mn +47.4%
2031 (forecast) $1.23 Bn +$91.9 Mn +59.3%
2032 (forecast) $1.33 Bn +$99.3 Mn +72.2%
2033 (forecast) $1.44 Bn +$107.3 Mn +86.1%
2034 (forecast) $1.55 Bn +$116.0 Mn +101.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Anastomosis Devices Market Analysis at a glance
Market size, 2025$772.6 Mn placeholder estimate
Forecast, 2034$1.55 Bn placeholder estimate
Growth (CAGR), 2025–20348.07% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, application and end user (see all)
Key playersMedtronic, LivaNova PLC, Johnson & Johnson, Stryker, MAQUET Holding B.V. & Co. KG and 2 more (see all)
Active clinical trials207 in Asia PacificSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Asia Pacific. Retrieved 9 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Anastomosis Devices Market Executive Summary

An anastomotic device is a surgical tool used to join blood vessels or other tubular structures in the body; it is made out of silk, resorbable and does not require suture applications. These devices are supposed to be easy to use, have high crush resistance and the ability to stimulate tissue regeneration.

The Anastomosis Devices Market is a relatively small and specific part of the medical device market, covering the equipment used for joining blood vessels or segments of the intestines during operations. It encompasses both mechanical and electronic applications and supports cardiovascular, gastrointestinal, and urological operations. It is fueled by technological innovations like the use of robots in surgery, minimal invasive procedures, increasing cases of chronic diseases and global population growing older. Notable manufacturers and developers are Medtronic, Johnson & Johnson, Stryker, and B. Braun Melsungen. However, like any market in its development stage, there are barriers including high costs and regulations. In general, the sector continues to positively develop due to constant innovations and the growth of surgical requirements.

Bar chart: Asia Pacific Anastomosis Devices market size, 2024–2034, placeholder estimates. $714.9 Mn in 2024, $772.6 Mn in 2025 and $1.55 Bn in 2034, 8.07% CAGR.
Asia Pacific Anastomosis Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Anastomosis Devices Market Dynamics

Market Growth Drivers

The rise in surgical anastomosis due to chronic diseases for instance, cardiovascular ailments, cancer and others has also boosted the market. Another factor adding to the increase is the tendency towards performing minimally invasive surgeries that have numerous advantages, including short periods of rehabilitation and less trauma. A growing aged populace, particularly in emerging markets such as Asia-Pacific, also increases the demand for such gadgets. Technologic innovations such as new materials and designs like stapling in the three dimensions offer better surgical results and productivity.

Opportunity

Computer aided and robotic surgery, fast track stapling and magnetically controlled anastomosis remain promising avenues to enhance surgical performance. There is potential for growth in BRIC countries and especially in Asia-Pacific which have tendency to strengthen their healthcare systems. This focus on biodegradable materials can coincides with heightened concern with patient safety and could spur market acceptance. Secondly, increasing instances of organ transplant surgeries necessitate the use of effective anastomosis devices.

Market Restraints

Higher prices of advanced devices can pose a problem as they remain expensive to acquire and implement especially in the constrained healthcare systems of developing nations. Problems like leaks and post-surgery bleeding may cause patients to refrain from using them, thus affecting patients’ well-being. High regulatory standards can slow down product releases and drive-up prices, while low reimbursement standards reduce access to these devices. Also, availability of less invasive techniques, could also lower the utilization rate for anastomosis procedures.

Competitive Landscape for Anastomosis Devices Market in APAC

Key Players

Recent Developments

August 2024, Colospan, which develops novel solutions for colorectal surgery, announced that USFDA has granted Breakthrough Device Designation to its CG-100 Intraluminal Bypass Device.

May 2024, Ethicon Launches ECHELON LINEAR™ Cutter, a First-of-its-Kind Surgical Stapler That Delivered 47% Fewer Leaks at the Staple Line to Help Reduce Surgical Risks.

May 2024, Sony Group Corporation (Sony) announced the development of a microsurgery assistance robot capable of automatic surgical instrument exchange and precision control. The prototype will be unveiled at the Sony booth during the 2024 Institute of Electrical and Electronics Engineers (IEEE) International Conference on Robotics and Automation (ICRA2024), which opens in Yokohama on May 13.

Healthcare Policies and Regulatory Landscape for Anastomosis Devices Market in APAC

Anastomosis Devices in APAC: rules, payment and research

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9] and Thai FDA (Thailand)⁠[10]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[11], basic medical insurance (China)⁠[12], the Hospital Authority (Hong Kong)⁠[13], Ayushman Bharat PM-JAY (India)⁠[14], public health insurance (Japan)⁠[15], subsidised public care (Malaysia)⁠[16], Pharmac (New Zealand)⁠[17], PhilHealth (Philippines)⁠[18], MediShield Life (Singapore)⁠[19] and the Universal Coverage Scheme (Thailand)⁠[20]. ClinicalTrials.gov lists 207 studies on Anastomosis Devices that are recruiting, active or about to start in APAC.⁠[21]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[12] National Healthcare Security Administration. Checked 14 Nov 2026.

[13] Hospital Authority. Checked 14 Nov 2026.

[14] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[15] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[16] Ministry of Health Malaysia. Checked 14 Nov 2026.

[17] Pharmac. Checked 14 Nov 2026.

[18] PhilHealth. Checked 14 Nov 2026.

[19] CPF Board, MediShield Life. Checked 14 Nov 2026.

[20] National Health Security Office. Checked 14 Nov 2026.

[21] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in APAC. Retrieved 9 Nov 2026.

Policy changes and Reimbursement scenario

Having favourable regulations in areas, such as North America and Europe where there is swift approvals for new and innovative devices, aids in boosting the market size. Lucrative clinical specifications demanding minimal invasiveness and recent healthcare policies in surgical operating room technology also contribute to the increase in demand for anastomosis devices. Reimbursement policies in developed countries are also favourable since they create demand while insufficient coverage in emerging markets is a concern. The global outbreak of COVID-19 has led to the postponement of elective procedures; however, as health systems adapt and move forward, there is likely to be a rise in demand for these devices due to better reimbursement situations.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Anastomosis Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Anastomosis Devices in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Anastomosis Devices market in Asia Pacific?
Placeholder estimate: about $772.6 Mn in 2025, rising to about $1.55 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Anastomosis Devices market in Asia Pacific growing?
Placeholder estimate: about 8.07% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Anastomosis Devices market report cover?
The report splits the market by type (Reusable Devices, Disposable Devices), application (Gastrointestinal Surgery, Cardiovascular Surgery, Others) and end user (Hospitals, Ambulatory Care Centres, Clinics).
Who are the key players in the Anastomosis Devices market?
Key players include Medtronic, LivaNova PLC, Johnson & Johnson, Stryker, MAQUET Holding B.V. & Co. KG and Dextera Surgical Inc., among 7 companies the report profiles.
What is driving the Anastomosis Devices market?
The rise in surgical anastomosis due to chronic diseases for instance, cardiovascular ailments, cancer and others has also boosted the market.
How many clinical trials on Anastomosis Devices are running in Asia Pacific?
207 studies are recruiting, active or about to start in Asia Pacific, counted across the 16 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Asia Pacific. Retrieved 9 Nov 2026.
How much research is published on Anastomosis Devices?
PubMed lists 1,598 papers on Anastomosis Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.
Back to Catalogue

Related Medical Devices reports in APAC

See all

Related on surgery

See the topic